Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

6 Stock Charts To Watch: APT, COCP, COE, MRNA, SPEX, VIR

Published 02/26/2020, 03:02 AM
Updated 07/09/2023, 06:31 AM

Alpha Pro Tech (NYSE:APT), which is a manufacturer of masks and containment gowns, was up 2.86, or 40%, to 10.00, on 19 million shares on Tuesday. This stock went in Jan from about 3 3/4 to 7 3/4, more than doubled, had a five-wave decline in a nice, orderly wedge on lower volume near the apex, and then it exploded, going from 4.80 to Tuesday’s high at 10.80, 6.00 in just four sessions. It might be a little overbought short term, but it might get an extension to 12, or 13, or 14 on Wednesday. Just be careful and add in your stops.

Cocrystal Pharma (NASDAQ:COCP) exploded on Monday, and again on Tuesday, gaining 86 cents, or 65%, to a high of 2.50, before pulling back and closing up 2.19, on 72.5 million shares. It literally went from 50 cents to 2.50, a 400% increase in two days. That’s heavy volume. Monday it traded 78 million shares and Tuesday 72.5 million. 150 million shares traded on a stock that has an average trading volume of 1669. There’s some resistance in the 3-dollar range, so maybe it will be tested on Wednesday. Keep an eye on it Wednesday morning.

China Online Education Group (NYSE:COE) is doing well right now because so many people in China are being sequestered and doing education online. On Tuesday, it was up 4.08, or 15.74%, to the session and multi-week high at 30.00, on 294,391 shares traded. It has gone from 5 to 30 since Dec in a 7-wave move. I’m not sure how much further it can go up, but the momentum is keen. It may go 5 points more to 35 before it pulls back. It’s due for some rest, but the momentum is very strong.

Moderna (NASDAQ:MRNA) exploded on the falling wedge with a little pop on Monday, and then a big jump on Tuesday on a breakaway gap of 5.17, or 27.8%, to 23.76, with a high of 26.55, on 63 million shares as it ships the first batch of its vaccine candidate. You can see the breakaway pop and the big move up. I have a target of 29 short term.

Spherix (NASDAQ:SPEX) exploded 1.41, or 137%, to 1.41, after reaching a session high at 3.69, on 24.3 million shares on Tuesday, an increase of nearly 600%. Let’s see if it will follow through. I wouldn’t be surprised to see a test of 4 1/4, and then we’ll see where we go from there.

Vir Biotechnology (NASDAQ:VIR) exploded from 12 to 29 the first part of Feb, pulled back into a falling wedge right to the 50, then ramped right back up on Tuesday and broke out, jumping 2.77, or 14.6%, closing at the session high at 21.73, on 734,512 shares traded, more than doubling average volume. I think 24 and 27 are the targets going forward.

Stocks on the long side

Alpha Pro Tech, Ltd. (APT), Brainstorm Cell Therapeutics Inc. (BCLI), Cocrystal Pharma, Inc. (COCP), Co-Diagnostics, Inc. (CODX), China Online Education Group (COE), the VelocityShares 3x Invrs Crude Oil ETNNew (DWT), Endo International plc (ENDP), GTT Communications, Inc. (GTT), Lakeland Industries, Inc. (LAKE), Lumber Liquidators Holdings, Inc. (LL), Moderna, Inc. (MRNA), NIO Inc. (NIO), Neoleukin Therapeutics, Inc. (NLTX), Realogy Holdings Corp. (RLGY), Spherix Incorporated (SPEX), the VelocityShares Daily 2x VIX ST ETN (TVIX), the ProShares Ultra VIX Short-Term Futures (UVXY), and Vir Biotechnology, Inc. (VIR).

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.